金吾财讯 | 诺和诺德(NVO)盘初走强，报50.60美元，涨3.77%。
消息面上，丹麦药企诺和诺德发函合作供应商，协商压低采购成本，意图扭转减肥药市场竞争劣势，抢夺礼来 (LLY) 占据的行业龙头地位。企业官方证实该项举措，称此举用于维持供应链商业可持续性，保障长期研发与经营能力。
诺和诺德表示供应商参与让利并非强制要求，但让利成效将纳入后续合作评估维度。丹麦财经媒体披露，多家供应商将本次施压视作合作风险信号，双方供需关系出现分歧。行业格局层面，2026 年一季度 GLP-1 减肥药赛道分化显著，礼来占据 60% 市场份额位居首位，诺和诺德以 40% 份额位列第二。降本举措并非单一动作，今年 9 月诺和诺德推出大规模裁员计划，拟全球裁减 9000 名员工，叠加本次供应链压价，共同组成新任 CEO 主导的全面降本方案，依托压缩开支优化产品定价，争夺减肥药赛道市场份额。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.